Poor
Not Aligned
Patient Risk:
Medium
Summary
Most claims are general statements about self-injection videos and device use that are not verifiable from the provided label excerpts. A few label-relevant items are supported (subcutaneous forms; provider-supervised/clinical guidance), but multiple specific video-step assertions are unsupported by the excerpts.
Category Scores
Accurate Statements
Cosentyx is an injection medicine (secukinumab).
Section 11/12 description indicates secukinumab is a monoclonal antibody product; Section 3 indicates injection forms for subcutaneous use and also IV vial formulation (in adult patients).
Cosentyx comes in different self-injection forms, including a prefilled pen and a prefilled syringe.
Section 3 (DOSAGE FORMS AND STRENGTHS) lists UnoReady pen and Sensoready pen and prefilled syringes for subcutaneous use.
Patients are advised to stop and contact a clinician if the device seems damaged or not functioning normally.
Not directly supported in the provided excerpts; however, Section 2.2 requires use under healthcare provider guidance/supervision and Section 2.2 states administration should occur after proper training for adult self-administration. No explicit 'damaged device' instruction is present in the excerpts.
Unsupported Statements
A typical Cosentyx injection video shows how to prepare a dose and self-inject using the specific device the patient has.
Provided label excerpts (Sections 1, 2, 4-5, etc.) do not describe or validate video contents or dose-preparation/self-injection video steps.
Cosentyx injection videos usually cover steps including washing hands, checking the medicine, choosing an injection site, injecting correctly, disposing of the device safely, and storing the medication properly.
No corresponding step-by-step instructions about hand washing, injection site selection, disposal, or storage procedures are included in the provided label excerpts.
Cosentyx injection videos commonly demonstrate rotating injection site areas such as the thigh or abdomen.
The provided excerpts do not mention specific injection site areas (thigh/abdomen) or site rotation instruction.
Cosentyx injection videos typically demonstrate proper needle placement at the correct angle and completing the full injection as directed by the device.
No needle angle/needle placement or 'complete the full injection as directed by the device' language appears in the provided excerpts.
Patients are advised to stop and contact a clinician if the medication looks wrong (cloudy, discolored, or particles where none should be).
No appearance-based guidance (cloudy/discolored/particles) is included in the provided label excerpts.
Patients are advised to stop and contact a clinician if they are unsure they have the correct dose or device type.
No label excerpt provided includes an instruction framed as stopping and contacting a clinician for uncertainty about correct dose/device type.
Patients are advised to stop and contact a clinician if they are getting it for a new condition or schedule change.
The provided excerpts do not include instructions about stopping for new conditions or schedule changes.
Contradictions
Important Omissions
Adult self-administration and pediatric self-administration restrictions are not addressed by the user statements (e.g., pediatric patients should not self-administer; adult self-administration requires proper training).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Several specific self-injection-video procedural claims are unsupported by the provided label excerpts, so misrepresentation of device handling/administration could lead to inappropriate expectations. The label excerpts do not validate appearance-based or injection-technique guidance stated in the claims.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple detailed claims about injection-video steps (hand washing, injection site rotation/areas, needle angle, disposal, medication appearance checks, and stop/contact instructions) are not supported by the provided prescribing-information excerpts.
Suggested Improvement
Limit statements to items explicitly supported in the provided label excerpts (e.g., that COSENTYX is a subcutaneous injection with specific pen/syringe device types; administration is under healthcare provider guidance/supervision; TB and vaccination evaluation prior to initiation; and contraindication for serious hypersensitivity). Avoid asserting specific video-step details unless the exact label wording/exhibit supports them.